Peter Mesenbrink, PhD is an Executive Director of Biostatistics at Novartis Pharmaceuticals Corporation in East Hanover, New Jersey. Peter received his PhD in Statistics from North Carolina State University in 1995. He joined Novartis in 1995 (then Ciba-Geigy) and is currently Executive Director Biostatistics and is the Therapeutic Area Head of Biostatistics for the Rheumatology/Musculoskeletal Disease Therapeutic Area. In addition to his many publications, Peter has many active external collaborations in Innovation in Complex Clinical Trial Designs (especially platform trials and other master protocols) and Exploratory Modeling/Data Sharing. He is the Lead for the DataCelerate platform at TransCelerate and as one of the founding members, is currently the Chair of the Board of Directors for the Clinical Research Data Sharing Alliance.